Breast cancer is the second most common cancer among American women. Breast cancer death rates have been falling over the past 30 years. But nearly 13% of women are still diagnosed in their lifetime.
Understanding genetic risks and identifying BRCA1 and BRCA2 mutations can guide preventive and personalised treatment strategies for patients at high risk of hereditary breast cancer.
Hormonal contraceptive use in BRCA1 mutation carriers was associated with increased risk of BC, with users having a proportional increase in risk of 3% for each year of hormonal contraceptive use. No ...